decisionhealth Newsletters, Coder Pink Sheets - 2003 Issue 1 (January)
CMS to re-review carpal tunnel test by Neurotron
Subscribe or sign in to view the full article.
Article Overview
This article reports on a CMS re-review of a sensory nerve testing service used in evaluating carpal tunnel syndrome and other sensory neuropathies. It is aimed at coding and billing professionals tracking Medicare coverage decisions, HCPCS changes, and payer policy developments that may affect reimbursement for this diagnostic service.
Why This Topic Matters
Coverage determinations for diagnostic testing can affect whether services are reimbursed and whether offices need to watch for code changes or policy updates. This piece helps readers monitor a Medicare review that could alter billing expectations for the service discussed.
Article Sections
-
CMS to re-review carpal tunnel test by Neurotron
Discussion of CMS reconsideration of evidence for a sensory nerve testing service, including its clinical context and the implications for Medicare coverage and reimbursement.
What You Will Learn
- What CMS is re-evaluating about this diagnostic testing service
- Why the article matters for Medicare coverage monitoring
- How a HCPCS deletion is part of the coverage update context
- Which organizations and stakeholders are involved in the review process
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Compliance teams
- Practice administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com